Tissue variations of mosaic genome-wide paternal uniparental disomy and phenotype of multi-syndromal congenital hyperinsulinism.
Beckwith-Wiedemann Syndrome
/ genetics
Child, Preschool
Chromosomes, Human
/ genetics
Congenital Hyperinsulinism
/ genetics
DNA Methylation
/ genetics
Female
Genetic Predisposition to Disease
Genome, Human
/ genetics
Genomic Imprinting
/ genetics
Humans
Mosaicism
Organ Specificity
/ genetics
Phenotype
Polymorphism, Single Nucleotide
/ genetics
Uniparental Disomy
/ genetics
Angelman syndrome
Beckwith-Wiedemann syndrome
Congenital hyperinsulinism
Genome-wide uniparental disomy
Mosaicism
Journal
European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
received:
17
12
2018
revised:
11
02
2019
accepted:
17
02
2019
pubmed:
24
2
2019
medline:
2
10
2020
entrez:
24
2
2019
Statut:
ppublish
Résumé
Mosaic genome-wide paternal uniparental disomy (GW-pUPD) is a rarely recognised disorder. The phenotypic manifestations of multilocus imprinting defects (MLIDs) remain unclear. We report of an apparently non-syndromic infant with severe congenital hyperinsulinism (CHI) and diffuse pancreatic labelling by 18F*-DOPA-PET/CT leading to near-total pancreatectomy. The histology was atypical with pronounced proliferation of endocrine cells comprising >70% of the pancreatic tissue and a small pancreatoblastoma. Routine genetic analysis for CHI was normal in the blood and resected pancreatic tissue. At two years' age, Beckwith-Wiedemann Syndrome (BWS) stigmata emerged, and at five years a liver tumour with focal nodular hyperplasia and an adrenal tumour were resected. pUPD was detected in 11p15 and next in the entire chromosome 11 with microsatellite markers. Quantitative fluorescent PCR with amplification of chromosome-specific DNA sequences for chromosomes 13, 18, 21 and X indicated GW-pUPD. A next generation sequencing panel with 303 SNPs on 21 chromosomes showed pUPD in both blood and pancreatic tissue. The mosaic distribution of GW-pUPD ranged from 31 to 35% in blood and buccal swap to 74% in the resected pancreas, 80% in a non-tumour liver biopsy, and 100% in the liver focal nodular hyperplasia and adrenal tumour. MLID features included transient conjugated hyperbilirubinaemia and lack of macrosomia from BWS (pUPD6); and behavioural and psychomotor manifestations of Angelman Syndrome (pUPD15) on follow-up. In conclusion, atypical pancreatic histology in apparently non-syndromic severe CHI patients may be the first clue to BWS and multi-syndromal CHI from GW-pUPD. Variations in the degree of mosaicism between tissues explained the phenotype.
Identifiants
pubmed: 30797057
pii: S1769-7212(18)30932-7
doi: 10.1016/j.ejmg.2019.02.004
pii:
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
103632Informations de copyright
Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.